Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtre
1.
Arch. endocrinol. metab. (Online) ; 60(5): 450-456, Oct. 2016. tab, graf
Article Dans Anglais | LILACS | ID: lil-798184

Résumé

ABSTRACT Objectives To assess the evolution to permanent or transient conditions in children with positive neonatal TSH tests in Sergipe, Brazil, from 2004 to 2010. Subjects and methods Out of 193,794 screened newborns, 713 presented a neonatal TSH level higher than the local cutoff (5.2 µU/mL). From the confirmatory serum TSH values, the children were diagnosed with initial congenital hypothyroidism (CH) or suspect CH. From the evolution, they were classified as permanent CH, hyperthyrotropinemia, or transient TSH elevation. The mean incidence of each final condition was calculated for the total period of time. Results The initial diagnosis included 37 CH (18.1%) and 167 suspect CH (81.9%) cases. The final diagnosis included 46 cases of permanent CH (22.5%), 56 of hyperthyrotropinemia (27.5%), and 102 of transient TSH elevation (50.0%). Out of the 37 cases of initial CH, 23 (62.2%) had permanent CH, nine (24.3%) had hyperthyrotropinemia, and five (13.5%) had transient TSH elevation. Out of the 167 suspect CH cases, 23 (13.8%) had permanent CH, 47 (28.1%) had hyperthyrotropinemia and 97 (58.1%) had transient TSH elevation. The mean incidence after the follow up was 1:4,166 for permanent CH, 1:3,448 for hyperthyrotropinemia, and 1:1,887 for transient TSH elevation. Eighty-six percent of the children with an initial diagnosis of CH and 41.9% with suspect CH had a permanent condition (CH or hyperthyrotropinemia). Conclusions The follow-up of children with an initial diagnosis of CH or suspect CH is necessary to determine whether the disorder is permanent because predicting the evolution of the condition is difficult.


Sujets)
Humains , Mâle , Femelle , Nouveau-né , Thyréostimuline/sang , Dépistage néonatal/méthodes , Hypothyroïdie congénitale/diagnostic , Hypothyroïdie congénitale/sang , Normes de référence , Valeurs de référence , Thyroxine/sang , Facteurs temps , Brésil/épidémiologie , Incidence , Valeur prédictive des tests , Études rétrospectives , Études de suivi , Évolution de la maladie , Hypothyroïdie congénitale/physiopathologie , Hypothyroïdie congénitale/épidémiologie
2.
Arch. endocrinol. metab. (Online) ; 59(2): 154-160, 04/2015. graf
Article Dans Anglais | LILACS | ID: lil-746467

Résumé

Obesity is currently a pandemic of worldwide proportions affecting millions of people. Recent studies have proposed the hypothesis that mechanisms not directly related to the human genome could be involved in the genesis of obesity, due to the fact that, when a population undergoes the same nutritional stress, not all individuals present weight gain related to the diet or become hyperglycemic. The human intestine is colonized by millions of bacteria which form the intestinal flora, known as gut flora. Studies show that lean and overweight human may present a difference in the composition of their intestinal flora; these studies suggest that the intestinal flora could be involved in the development of obesity. Several mechanisms explain the correlation between intestinal flora and obesity. The intestinal flora would increase the energetic extraction of non-digestible polysaccharides. In addition, the lipopolysaccharide from intestinal flora bacteria could trigger a chronic sub-clinical inflammatory process, leading to obesity and diabetes. Another mechanism through which the intestinal flora could lead to obesity would be through the regulation of genes of the host involved in energy storage and expenditure. In the past five years data coming from different sources established causal effects between intestinal microbiota and obesity/insulin resistance, and it is clear that this area will open new avenues of therapeutic to obesity, insulin resistance and DM2.


Sujets)
Animaux , Humains , Souris , Microbiome gastro-intestinal/génétique , Obésité/microbiologie , , /microbiologie , Métabolisme énergétique , Inflammation/microbiologie , Obésité/thérapie
4.
Arq. bras. endocrinol. metab ; 53(2): 139-144, Mar. 2009. ilus
Article Dans Anglais | LILACS | ID: lil-513767

Résumé

Obesity is a pandemic which has been rapidly developing for three decades. When a population is submitted to the same nutritional stress, some individuals are less susceptible to diet-induced weight gain and hyperglycemia. This observation suggests that other mechanisms are involved which are not directly related to the human genome. The human gut contains an immense number of microorganisms, collectively known as the microbiota. Evidence that gut microbiota composition can differ between obese and lean humans has led to the speculation that gut microbiota can participate in the pathophysiology of obesity. Different mechanisms have been proposed to explain the link between gut flora and obesity. The first mechanism consists in the role of the gut microbiota to increase energy extraction from indigestible dietary polysaccharides. The second, consists in the role of gut flora to modulate plasma lipopolysaccharide levels which triggers chronic low-grade inflammation leading to obesity and diabetes. A third mechanism proposes that gut microbiota may induce regulation of host genes that modulate how energy is expended and stored. However, further studies are needed to clarify a number of issues related to the relationship between the gut microbiota and obesity.


A obesidade é uma pandemia que afeta milhões de pessoas em todo o mundo. Quando uma população é submetida ao mesmo estresse nutricional, alguns indivíduos são menos suscetíveis ao ganho de peso induzido pela dieta e à hiperglicemia. Essa observação sugere que outros mecanismos não diretamente relacionados ao genoma humano estejam envolvidos. O intestino humano é colonizado por milhões de bactérias, que coletivamente constituem a flora comensal normal. A evidência de que a composição da flora intestinal pode ser diferente em humanos magros e obesos levou à especulação de que a flora intestinal pode participar na fisiopatologia da obesidade. Diferentes mecanismos foram propostos para tentar explicar a correlação entre flora intestinal e obesidade. O primeiro mecanismo consiste no papel da flora intestinal na extração de energia de polissacarídeos não digeríveis. O segundo mecanismo envolve a modulação dos níveis de lipopolissacarídeo pela flora intestinal, o que desencadeia uma inflamação crônica subclínica que acarreta obesidade e diabetes. Um terceiro mecanismo propõe que a flora intestinal pode induzir a regulação de genes do hospedeiro que modulam como a energia é gasta e armazenada. Entretanto, estudos adicionais são necessários para estabelecer o papel da flora intestinal no desenvolvimento da obesidade.


Sujets)
Animaux , Humains , Phénomènes physiologiques bactériens , Intestins/microbiologie , Métagénome , Obésité/microbiologie , Matières grasses alimentaires/administration et posologie , Ration calorique , Métabolisme énergétique , Intestins/métabolisme , Lipopolysaccharides/métabolisme , Obésité/étiologie , Obésité/physiopathologie , Obésité/thérapie , Polyosides/composition chimique ,
5.
Mem. Inst. Oswaldo Cruz ; 101(supl.1): 353-354, Oct. 2006. graf
Article Dans Anglais | LILACS | ID: lil-441273

Résumé

Evaluation of hepatic fibrosis is usually performed by histopathological examination of biopsies. However, this is an invasive and potentially dangerous procedure. Several studies have proposed serum biological markers of hepatic fibrosis. This communication evaluates the use of serum cytokines as markers of hepatic fibrosis in hepatitis C, schistosomiasis, and co-infection.


Sujets)
Adulte , Humains , Cytokines/sang , Hépatite C/immunologie , Cirrhose du foie/parasitologie , Schistosomiase/immunologie , Marqueurs biologiques/sang , Cytokines/immunologie , Test ELISA , Hépatite C/complications , /sang , Cirrhose du foie/immunologie , Valeur prédictive des tests , Reproductibilité des résultats , Schistosomiase/complications , Facteur de croissance transformant bêta/sang , Facteur de nécrose tumorale alpha/sang
SÉLECTION CITATIONS
Détails de la recherche